Anil Kapur's Net Worth
$1.5 Million
Who is Anil Kapur?
Anil Kapur has an estimated net worth of $1.5 Million. This is based on reported shares across multiple companies, which include GERON CORP, Actinium Pharmaceuticals, Inc., and Verastem, Inc..
SEC CIK
Anil Kapur's CIK is 0001730703
Past Insider Trading and Trends
2024 was Anil Kapur's most active year for acquiring shares with 5 total transactions. Anil Kapur's most active month to acquire stocks was the month of May. 2024 was Anil Kapur's most active year for disposing of shares, totalling 2 transactions. Anil Kapur's most active month to dispose stocks was the month of May. 2024 saw Anil Kapur paying a total of $447,187.50 for 1,442,708 shares, this is the most they've acquired in one year. In 2024 Anil Kapur cashed out on 843,750 shares for a total of $1,959,609.37, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GERON CORP (GERN) Snapshot price: $4.29
EVP, Corp Strategy & CCO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$2.85 | -$1,512,421.87 |
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +14.22% | 7.57K |
$2.04 | $15,436.68 | 60.78K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
| +12.76% | 6.02K |
$1.11 | $6,683.31 | 53.22K |
Dec 30
| |||
Form 4
| +38.27% | 13.06K |
$1.11 | $14,498.82 | 47.2K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
| No matching records found | |||||||||
Actinium Pharmaceuticals, Inc. (ATNM) Snapshot price: $1.71
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verastem, Inc. (VSTM) Snapshot price: $2.44
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 8.33K |
—
|
—
| 8.33K |
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nurix Therapeutics, Inc. (NRIX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||